A panel of urinary volatile biomarkers for differential diagnosis of prostate cancer from other urological cancers
Our group recently developed a urinary 6-biomarker panel for the diagnosis of prostate cancer (PCa) which has a higher level of accuracy compared to the serum prostate specific antigen (PSA) test. Herein, urine from an independent cohort of PCa patients and cancer-free controls was analyzed to furth...
Autor principal: | |
---|---|
Outros Autores: | , , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2021
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10284/10015 |
País: | Portugal |
Oai: | oai:bdigital.ufp.pt:10284/10015 |